The intended indication is for the treatment of major depressive disorder.
Conditions
Interventions
None listed
Sponsors
CCDRD Cooperative Clinical Drug Research and Development AG, Corium Innovations Inc.
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Outcome results
None listed